tirzepatide from india one step closer to approving weight-loss drug tirzepatide: What is it? How does it work? – Firstpost Most Advanced Weight Loss Drug

Discussion In a population of patients with type 2 diabetes who had no prior diagnosis of eye diseases, this cohort study found that semaglutide or tirzepatide compared with other antidiabetic medications was associated with a differential risk of optic nerve and visual pathways, including increased risk of NAION and other optic nerve disorders, but not optic neuritis, papilledema, optic atrophy, or optic disc orders

a concurrent glucose measurement was not required

Funding This research was funded by the Deputyship for Research & Innovation, Ministry of Education, in Saudi Arabia, which has supported this research work with the project number (UB-14-1442)

doi: 10.1002/edm2.489